Patent · US Active

Modulators

US9725510B2 · kind B2 · utility

1Cited by
39References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 26, 2014
Grant dateAug 8, 2017
Priority date—
Expiry dateOct 25, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Antibodies that modulate insulin receptor signaling are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.